FindTrial
Sign In

Clinical Research on the Treatment of Uterine Fibroids with Xiao Ai Fei Mi Gao

Clinical Research on the Treatment of Uterine Fibroids with Xiaoi Feimi Ointment

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001770
Enrollment
Unknown
Registered
2025-09-18
Start date
2025-04-17
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine fibroids

Interventions

Treatment group :During the treatment of uterine fibroids, patients first use maturation agents and purgatives to regulate their condition. Subsequently, the following options can be selected: First,
Second, use both the hospital - prepared Xiaofei Feimi Ointment and Weicheng Medicine Qingre Kaisen Granules simultaneously for combined therapy
Third, treat with other hospital - prepared agents or Weicheng Medicine instead of Xiaofei Feimi Ointment. In addition, based on the patients physical constitution, appropriate prescriptions or decoct

Sponsors

Xinjiang Uyghur Autonomous Region Uyghur Medical Hospita Affiliation
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Treatment group : 1)Meet the diagnostic criteria for uterine fibroids; 2)Aged between 20 and 50 years with a history of sexual activity; 3)No indication for surgery; 4)Voluntarily participate in this study and sign the informed consent form, and are willing to actively cooperate with the treatment and undergo regular follow - ups.

Exclusion criteria

Exclusion criteria: Exclusion Criteria 1.Women who are pregnant planning to become pregnant breastfeeding or postmenopausal. 2.Women using a medicated intrauterine device (IUD) for contraception. 3.Women who have used sex - hormone - related drugs within the past 3 months. 4.Women with special - location fibroids: submucosal fibroids pedunculated serosal fibroids cervical fibroids etc.1.

Design outcomes

Primary

MeasureTime frame
Observation of Fibroid Volume - Uterine Fibroid Reduction Rate;—

Secondary

MeasureTime frame
Medical Infrared Thermography Examination;Observation of Uterine Volume and Endometrial Thickness;Sex Hormones Examination;Routine Gynecological Examination;TCM Meridian Conduction Detection System;Traditional Chinese Medicine (TCM) Constitution Identification System;—

Countries

China

Contacts

Public ContactNiloofar Setiwardi/Ajiguli Amiti

Xinjiang Uyghur Autonomous Region Uyghur Medical Hospita Affiliation

nilufar5158@163.com13899929828

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026